

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.29124358 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.43520461 |
| 3 | neutrophil activation (GO:0042119) | 4.76573735 |
| 4 | granulocyte activation (GO:0036230) | 4.41389665 |
| 5 | positive regulation of antigen processing and presentation (GO:0002579) | 4.38262989 |
| 6 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.37063694 |
| 7 | type I interferon signaling pathway (GO:0060337) | 4.27562227 |
| 8 | cellular response to type I interferon (GO:0071357) | 4.27562227 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 4.20928473 |
| 10 | response to type I interferon (GO:0034340) | 4.18911873 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.04463977 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04266369 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.04266369 |
| 14 | regulation of activation of Janus kinase activity (GO:0010533) | 4.02945171 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 3.92306435 |
| 16 | myeloid dendritic cell activation (GO:0001773) | 3.87965193 |
| 17 | myeloid dendritic cell differentiation (GO:0043011) | 3.87114988 |
| 18 | regulation of RIG-I signaling pathway (GO:0039535) | 3.83919930 |
| 19 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.82903413 |
| 20 | regulation of antigen processing and presentation (GO:0002577) | 3.78135740 |
| 21 | response to peptidoglycan (GO:0032494) | 3.76454426 |
| 22 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.70527348 |
| 23 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.64704551 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62683169 |
| 25 | negative regulation of viral genome replication (GO:0045071) | 3.57585278 |
| 26 | T-helper 1 type immune response (GO:0042088) | 3.56938690 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.50011808 |
| 28 | respiratory burst (GO:0045730) | 3.49299641 |
| 29 | positive regulation of interleukin-12 production (GO:0032735) | 3.48371204 |
| 30 | myeloid cell activation involved in immune response (GO:0002275) | 3.44498199 |
| 31 | dendritic cell chemotaxis (GO:0002407) | 3.44113073 |
| 32 | positive regulation of type 2 immune response (GO:0002830) | 3.43304025 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.42314594 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.42314594 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.42314594 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.42314594 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.42314594 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.42314594 |
| 39 | cellular response to zinc ion (GO:0071294) | 3.42152204 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.40274066 |
| 41 | detection of other organism (GO:0098543) | 3.34847426 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.33117059 |
| 43 | dendritic cell differentiation (GO:0097028) | 3.32367641 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.27431093 |
| 45 | myeloid leukocyte activation (GO:0002274) | 3.25565333 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.25252194 |
| 47 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.24562190 |
| 48 | mast cell activation (GO:0045576) | 3.23134834 |
| 49 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.22962955 |
| 50 | negative regulation of interleukin-17 production (GO:0032700) | 3.22036980 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20265246 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.19550449 |
| 53 | defense response to protozoan (GO:0042832) | 3.18595073 |
| 54 | superoxide anion generation (GO:0042554) | 3.18369521 |
| 55 | regulation of hypersensitivity (GO:0002883) | 3.18305311 |
| 56 | sequestering of actin monomers (GO:0042989) | 3.15722734 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13941630 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13941630 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.13736954 |
| 60 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.12561371 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12330916 |
| 62 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11212406 |
| 63 | monocyte chemotaxis (GO:0002548) | 3.10461454 |
| 64 | cellular extravasation (GO:0045123) | 3.08512201 |
| 65 | detection of bacterium (GO:0016045) | 3.06627035 |
| 66 | dendritic cell migration (GO:0036336) | 3.05629317 |
| 67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05144566 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.04190665 |
| 69 | cellular response to interferon-beta (GO:0035458) | 3.03481941 |
| 70 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.03343719 |
| 71 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03110296 |
| 72 | leukocyte degranulation (GO:0043299) | 3.01896227 |
| 73 | eosinophil chemotaxis (GO:0048245) | 3.01217235 |
| 74 | positive regulation of T cell migration (GO:2000406) | 3.00882282 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.99329579 |
| 76 | positive regulation of interferon-beta production (GO:0032728) | 2.98565596 |
| 77 | NIK/NF-kappaB signaling (GO:0038061) | 2.96248742 |
| 78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.95636603 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94105935 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 2.94105935 |
| 81 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93892790 |
| 82 | natural killer cell mediated immunity (GO:0002228) | 2.93019544 |
| 83 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.93019544 |
| 84 | macrophage activation (GO:0042116) | 2.93004671 |
| 85 | regulation of mast cell activation (GO:0033003) | 2.92666174 |
| 86 | detection of external biotic stimulus (GO:0098581) | 2.91310342 |
| 87 | detection of molecule of bacterial origin (GO:0032490) | 2.91157082 |
| 88 | response to interferon-beta (GO:0035456) | 2.90748533 |
| 89 | negative regulation of mast cell activation (GO:0033004) | 2.88867833 |
| 90 | positive regulation of mast cell activation (GO:0033005) | 2.87684173 |
| 91 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.87196835 |
| 92 | regulation of interleukin-17 production (GO:0032660) | 2.86421803 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86173749 |
| 94 | cellular response to virus (GO:0098586) | 2.85341350 |
| 95 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.82091973 |
| 96 | lipoxygenase pathway (GO:0019372) | 2.80425110 |
| 97 | response to interferon-alpha (GO:0035455) | 2.80287098 |
| 98 | response to host immune response (GO:0052572) | 2.79905108 |
| 99 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.79905108 |
| 100 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.79220458 |
| 101 | microglial cell activation (GO:0001774) | 2.79217733 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78672193 |
| 103 | positive regulation of lymphocyte migration (GO:2000403) | 2.78310490 |
| 104 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.78000067 |
| 105 | leukocyte mediated cytotoxicity (GO:0001909) | 2.77651003 |
| 106 | regulation of T cell tolerance induction (GO:0002664) | 2.77408375 |
| 107 | germinal center formation (GO:0002467) | 2.76037305 |
| 108 | response to protozoan (GO:0001562) | 2.73698797 |
| 109 | negative thymic T cell selection (GO:0045060) | 2.72898129 |
| 110 | positive regulation of T cell chemotaxis (GO:0010820) | 2.71688895 |
| 111 | regulation of T cell chemotaxis (GO:0010819) | 2.71688895 |
| 112 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.70397078 |
| 113 | negative regulation of interleukin-12 production (GO:0032695) | 2.65783205 |
| 114 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.51237845 |
| 115 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.45300945 |
| 116 | detection of biotic stimulus (GO:0009595) | 2.43221885 |
| 117 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.42834190 |
| 118 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.38433387 |
| 119 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.33410780 |
| 120 | T-helper cell differentiation (GO:0042093) | 2.33410780 |
| 121 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.32535883 |
| 122 | tolerance induction (GO:0002507) | 2.31769534 |
| 123 | response to interleukin-15 (GO:0070672) | 2.31297877 |
| 124 | regulation of leukocyte degranulation (GO:0043300) | 2.30758693 |
| 125 | negative regulation of innate immune response (GO:0045824) | 2.30758657 |
| 126 | macroautophagy (GO:0016236) | 2.30387193 |
| 127 | T cell selection (GO:0045058) | 2.27064704 |
| 128 | negative regulation of interleukin-6 production (GO:0032715) | 2.26801339 |
| 129 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.26744996 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.26534678 |
| 131 | regulation of tolerance induction (GO:0002643) | 2.23824231 |
| 132 | cellular response to interleukin-15 (GO:0071350) | 2.23407333 |
| 133 | positive thymic T cell selection (GO:0045059) | 2.23020379 |
| 134 | negative T cell selection (GO:0043383) | 2.20889987 |
| 135 | negative regulation of T cell mediated immunity (GO:0002710) | 2.19800670 |
| 136 | positive regulation of Rap GTPase activity (GO:0032854) | 2.19057013 |
| 137 | regulation of cellular extravasation (GO:0002691) | 2.14545011 |
| 138 | * positive regulation of cholesterol efflux (GO:0010875) | 2.14415929 |
| 139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.14314076 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.14199452 |
| 141 | regulation of beta-amyloid formation (GO:1902003) | 2.14036669 |
| 142 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.13518374 |
| 143 | response to host (GO:0075136) | 2.13339680 |
| 144 | response to host defenses (GO:0052200) | 2.13339680 |
| 145 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.13339680 |
| 146 | regulation of germinal center formation (GO:0002634) | 2.12782760 |
| 147 | B cell receptor signaling pathway (GO:0050853) | 2.12633445 |
| 148 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.11872871 |
| 149 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.11872871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.11262223 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.92280783 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.60354525 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.87589895 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.54547532 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99092502 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62456023 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31541428 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.07615112 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00393792 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90839231 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76249874 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70361870 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.61924851 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41805086 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39608486 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.28548477 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10643296 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07546042 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07529968 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93327561 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83435378 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81024516 |
| 24 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78584024 |
| 25 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75475414 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74984933 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74578607 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.73396179 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60860812 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59587601 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58572102 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56369694 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.55943543 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54403070 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53886294 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53366907 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52074424 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50555749 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.49981021 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49599598 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48379390 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45935974 |
| 43 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42654793 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39870936 |
| 45 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39537976 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38468751 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37340525 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36890731 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36624815 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29101306 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26769182 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24764753 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23449520 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23395605 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22719446 |
| 56 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.22528383 |
| 57 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22227139 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21833362 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21833362 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20532872 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20397832 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19044210 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18755623 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18612257 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14283955 |
| 66 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12794957 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11501543 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10900086 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.10510458 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10230128 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10148868 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10048017 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08607762 |
| 74 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08530930 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07666323 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07297210 |
| 77 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06079969 |
| 78 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05463625 |
| 79 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05399036 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05306358 |
| 81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04602690 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04485871 |
| 83 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03772727 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02370576 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01379436 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01120451 |
| 87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01090893 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99535924 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98908246 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98638312 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 0.98371553 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97901414 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97543433 |
| 94 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.96797024 |
| 95 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95863446 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95649391 |
| 97 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.95151815 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95129671 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94686350 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94579459 |
| 101 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94190366 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93852504 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93148767 |
| 104 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92926133 |
| 105 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.92608142 |
| 106 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91498069 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91445913 |
| 108 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91160941 |
| 109 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90293443 |
| 110 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.89842315 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89698558 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88997283 |
| 113 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88012760 |
| 114 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87163588 |
| 115 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87028882 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86506152 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86388749 |
| 118 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84998520 |
| 119 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.84422358 |
| 120 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.84357979 |
| 121 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84147394 |
| 122 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84039656 |
| 123 | MAF_26560356_Chip-Seq_TH1_Human | 0.83826377 |
| 124 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.83589191 |
| 125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83304199 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83012410 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82920515 |
| 128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82103384 |
| 129 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.82019902 |
| 130 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81533761 |
| 131 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80996961 |
| 132 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80977626 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79435292 |
| 134 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79435292 |
| 135 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.79402360 |
| 136 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78928375 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78315061 |
| 138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77268881 |
| 139 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.77074810 |
| 140 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.76496978 |
| 141 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76361305 |
| 142 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75838895 |
| 143 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.74735572 |
| 144 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.73213500 |
| 145 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.72979486 |
| 146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72910945 |
| 147 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.72188292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.31302232 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.10565290 |
| 3 | MP0009785_altered_susceptibility_to | 3.63218989 |
| 4 | MP0001790_abnormal_immune_system | 3.23794479 |
| 5 | MP0005387_immune_system_phenotype | 3.23794479 |
| 6 | MP0005671_abnormal_response_to | 3.15313002 |
| 7 | MP0003436_decreased_susceptibility_to | 3.14391366 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.06437194 |
| 9 | MP0000685_abnormal_immune_system | 2.91061427 |
| 10 | * MP0002419_abnormal_innate_immunity | 2.88155360 |
| 11 | MP0005025_abnormal_response_to | 2.78597671 |
| 12 | MP0003724_increased_susceptibility_to | 2.78561401 |
| 13 | MP0004510_myositis | 2.60662332 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.56520161 |
| 15 | * MP0002723_abnormal_immune_serum | 2.47491554 |
| 16 | MP0006082_CNS_inflammation | 2.43018098 |
| 17 | MP0001800_abnormal_humoral_immune | 2.42617533 |
| 18 | MP0005310_abnormal_salivary_gland | 2.41024426 |
| 19 | * MP0001819_abnormal_immune_cell | 2.31173927 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.27544050 |
| 21 | * MP0003191_abnormal_cellular_cholesterol | 2.18394139 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.12561804 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 2.09364360 |
| 24 | MP0002163_abnormal_gland_morphology | 2.07554251 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.97512800 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.90808630 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.86394405 |
| 28 | MP0005451_abnormal_body_composition | 1.85483706 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.81544064 |
| 30 | MP0001346_abnormal_lacrimal_gland | 1.77419363 |
| 31 | * MP0002405_respiratory_system_inflammati | 1.76893130 |
| 32 | MP0001853_heart_inflammation | 1.71303201 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.69197564 |
| 34 | MP0002254_reproductive_system_inflammat | 1.63678592 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.62389879 |
| 36 | * MP0000716_abnormal_immune_system | 1.62000123 |
| 37 | MP0009764_decreased_sensitivity_to | 1.60972674 |
| 38 | MP0005379_endocrine/exocrine_gland_phen | 1.58822264 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.57521064 |
| 40 | MP0002006_tumorigenesis | 1.56011953 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.55698361 |
| 42 | * MP0009840_abnormal_foam_cell | 1.55591276 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.53873893 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.53658785 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.48740691 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.47039755 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.46016701 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.45343919 |
| 49 | MP0004381_abnormal_hair_follicle | 1.44365717 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.44242299 |
| 51 | * MP0002398_abnormal_bone_marrow | 1.42982485 |
| 52 | MP0009278_abnormal_bone_marrow | 1.41701803 |
| 53 | MP0003075_altered_response_to | 1.39953307 |
| 54 | MP0002009_preneoplasia | 1.39597066 |
| 55 | MP0004130_abnormal_muscle_cell | 1.38674040 |
| 56 | MP0008469_abnormal_protein_level | 1.33264089 |
| 57 | MP0001873_stomach_inflammation | 1.31619277 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.29801704 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.29114344 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.21861295 |
| 61 | MP0005171_absent_coat_pigmentation | 1.20540847 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.20425014 |
| 63 | MP0003448_altered_tumor_morphology | 1.20335187 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.17792132 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.17115561 |
| 66 | * MP0002429_abnormal_blood_cell | 1.17087277 |
| 67 | MP0004947_skin_inflammation | 1.17012141 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.16061886 |
| 69 | MP0003690_abnormal_glial_cell | 1.16032718 |
| 70 | MP0000343_altered_response_to | 1.14733808 |
| 71 | MP0004484_altered_response_of | 1.14006584 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.13835945 |
| 73 | MP0003303_peritoneal_inflammation | 1.10644790 |
| 74 | MP0000372_irregular_coat_pigmentation | 1.10420332 |
| 75 | MP0002909_abnormal_adrenal_gland | 1.10338765 |
| 76 | MP0003329_amyloid_beta_deposits | 1.05604296 |
| 77 | MP0002722_abnormal_immune_system | 1.03657623 |
| 78 | MP0002132_abnormal_respiratory_system | 1.03483604 |
| 79 | MP0001765_abnormal_ion_homeostasis | 1.00828236 |
| 80 | MP0008004_abnormal_stomach_pH | 0.94957362 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.94306179 |
| 82 | MP0001545_abnormal_hematopoietic_system | 0.93517439 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.93517439 |
| 84 | MP0000920_abnormal_myelination | 0.93387277 |
| 85 | MP0003186_abnormal_redox_activity | 0.92693172 |
| 86 | * MP0005535_abnormal_body_temperature | 0.92474151 |
| 87 | * MP0004782_abnormal_surfactant_physiolog | 0.91629587 |
| 88 | MP0000249_abnormal_blood_vessel | 0.91070423 |
| 89 | * MP0002971_abnormal_brown_adipose | 0.89652738 |
| 90 | MP0003879_abnormal_hair_cell | 0.88510289 |
| 91 | MP0003045_fibrosis | 0.87134145 |
| 92 | MP0002796_impaired_skin_barrier | 0.86861654 |
| 93 | MP0005365_abnormal_bile_salt | 0.84592413 |
| 94 | MP0001501_abnormal_sleep_pattern | 0.84420331 |
| 95 | MP0000858_altered_metastatic_potential | 0.83847735 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.81711646 |
| 97 | MP0004883_abnormal_blood_vessel | 0.81291153 |
| 98 | MP0005334_abnormal_fat_pad | 0.81228478 |
| 99 | MP0002933_joint_inflammation | 0.79347682 |
| 100 | MP0009763_increased_sensitivity_to | 0.78235507 |
| 101 | MP0005166_decreased_susceptibility_to | 0.77135425 |
| 102 | * MP0002118_abnormal_lipid_homeostasis | 0.76568968 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.76463678 |
| 104 | MP0000604_amyloidosis | 0.76400219 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.76043538 |
| 106 | MP0000681_abnormal_thyroid_gland | 0.75672656 |
| 107 | MP0008260_abnormal_autophagy | 0.75506807 |
| 108 | MP0001663_abnormal_digestive_system | 0.75336157 |
| 109 | MP0001502_abnormal_circadian_rhythm | 0.75228827 |
| 110 | MP0010329_abnormal_lipoprotein_level | 0.74280464 |
| 111 | MP0010678_abnormal_skin_adnexa | 0.73882805 |
| 112 | * MP0009115_abnormal_fat_cell | 0.73879639 |
| 113 | MP0008874_decreased_physiological_sensi | 0.73176054 |
| 114 | MP0005390_skeleton_phenotype | 0.72678937 |
| 115 | MP0001984_abnormal_olfaction | 0.70868654 |
| 116 | MP0004036_abnormal_muscle_relaxation | 0.68597412 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.68227010 |
| 118 | MP0008789_abnormal_olfactory_epithelium | 0.65961590 |
| 119 | MP0003136_yellow_coat_color | 0.65456193 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.65423722 |
| 121 | MP0005164_abnormal_response_to | 0.62438380 |
| 122 | MP0005645_abnormal_hypothalamus_physiol | 0.62211537 |
| 123 | MP0003866_abnormal_defecation | 0.59898217 |
| 124 | MP0002090_abnormal_vision | 0.59771904 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.58647302 |
| 126 | MP0003828_pulmonary_edema | 0.58173889 |
| 127 | MP0002095_abnormal_skin_pigmentation | 0.57291448 |
| 128 | MP0005646_abnormal_pituitary_gland | 0.56806629 |
| 129 | MP0001188_hyperpigmentation | 0.56717919 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.55862478 |
| 131 | MP0004742_abnormal_vestibular_system | 0.55418783 |
| 132 | MP0000371_diluted_coat_color | 0.55254990 |
| 133 | MP0001851_eye_inflammation | 0.54526634 |
| 134 | MP0002396_abnormal_hematopoietic_system | 0.54267192 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.53561888 |
| 136 | MP0000703_abnormal_thymus_morphology | 0.53131109 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.52566568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.23230487 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.00814454 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.90268883 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.59808983 |
| 5 | Increased IgM level (HP:0003496) | 4.56291578 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.51609776 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.07256193 |
| 8 | Optic neuritis (HP:0100653) | 4.06453930 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.06453930 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.03084448 |
| 11 | Myositis (HP:0100614) | 3.83135456 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.79777323 |
| 13 | Orchitis (HP:0100796) | 3.79692963 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.79664042 |
| 15 | Recurrent skin infections (HP:0001581) | 3.73814990 |
| 16 | Chronic otitis media (HP:0000389) | 3.68803233 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.67400570 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.66349900 |
| 19 | Gingivitis (HP:0000230) | 3.31038007 |
| 20 | Vasculitis (HP:0002633) | 3.21318494 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 3.20014371 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.18916752 |
| 23 | Recurrent viral infections (HP:0004429) | 3.15857885 |
| 24 | Loss of speech (HP:0002371) | 3.14396824 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.13359891 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.13359891 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.13359891 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.04935444 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.04935444 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.01948602 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.01794890 |
| 32 | Basal ganglia calcification (HP:0002135) | 2.99055465 |
| 33 | Recurrent pneumonia (HP:0006532) | 2.91503724 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89634202 |
| 35 | Obstructive lung disease (HP:0006536) | 2.89634202 |
| 36 | Axonal loss (HP:0003447) | 2.89297294 |
| 37 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.86628171 |
| 38 | Prostate neoplasm (HP:0100787) | 2.85712543 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.82196353 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.82196353 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.82196353 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.79217035 |
| 43 | Meningitis (HP:0001287) | 2.74797798 |
| 44 | Increased CSF protein (HP:0002922) | 2.68993168 |
| 45 | Periodontitis (HP:0000704) | 2.68936101 |
| 46 | Cellulitis (HP:0100658) | 2.68687406 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.66392059 |
| 48 | Eosinophilia (HP:0001880) | 2.66391637 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.61467320 |
| 50 | Hematochezia (HP:0002573) | 2.60818125 |
| 51 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.56372578 |
| 52 | Hypothermia (HP:0002045) | 2.49126060 |
| 53 | Petechiae (HP:0000967) | 2.48328494 |
| 54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.46150443 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.45630698 |
| 56 | Osteomyelitis (HP:0002754) | 2.45604190 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.43275703 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.43056666 |
| 59 | Prolonged neonatal jaundice (HP:0006579) | 2.41455775 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.39144624 |
| 61 | Leukocytosis (HP:0001974) | 2.38264576 |
| 62 | Thick nail (HP:0001805) | 2.36058813 |
| 63 | Stomatitis (HP:0010280) | 2.31859674 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.30651467 |
| 65 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28809326 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.27907454 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25369234 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.25267996 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.23091399 |
| 70 | Progressive visual loss (HP:0000529) | 2.20882043 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.19159599 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.18701763 |
| 73 | Granulocytopenia (HP:0001913) | 2.18138159 |
| 74 | Thyroiditis (HP:0100646) | 2.17949695 |
| 75 | Arterial thrombosis (HP:0004420) | 2.16727500 |
| 76 | Hemoptysis (HP:0002105) | 2.10660676 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.09533469 |
| 78 | Neurofibrillary tangles (HP:0002185) | 2.09474903 |
| 79 | Joint hemorrhage (HP:0005261) | 2.09269443 |
| 80 | Ventricular fibrillation (HP:0001663) | 2.09010428 |
| 81 | Stomach cancer (HP:0012126) | 2.08256524 |
| 82 | Increased IgE level (HP:0003212) | 2.08071946 |
| 83 | Malnutrition (HP:0004395) | 2.06448666 |
| 84 | Urticaria (HP:0001025) | 2.06040495 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.05746323 |
| 86 | Lip pit (HP:0100267) | 2.04019783 |
| 87 | Exercise-induced myalgia (HP:0003738) | 2.03195421 |
| 88 | Pulmonary embolism (HP:0002204) | 2.02509733 |
| 89 | Chest pain (HP:0100749) | 2.02159877 |
| 90 | Cheilitis (HP:0100825) | 2.01122058 |
| 91 | Gingival bleeding (HP:0000225) | 2.00591078 |
| 92 | Encephalitis (HP:0002383) | 1.99300728 |
| 93 | Colitis (HP:0002583) | 1.98109791 |
| 94 | Inflammation of the large intestine (HP:0002037) | 1.96976498 |
| 95 | Pustule (HP:0200039) | 1.93531837 |
| 96 | Sepsis (HP:0100806) | 1.91990809 |
| 97 | Hyporeflexia of lower limbs (HP:0002600) | 1.91962468 |
| 98 | Prolonged bleeding time (HP:0003010) | 1.90578214 |
| 99 | Recurrent bronchitis (HP:0002837) | 1.89360015 |
| 100 | Decreased circulating renin level (HP:0003351) | 1.89100654 |
| 101 | Chronic diarrhea (HP:0002028) | 1.87586515 |
| 102 | IgG deficiency (HP:0004315) | 1.87412667 |
| 103 | Alveolar cell carcinoma (HP:0006519) | 1.87317764 |
| 104 | Pigmentary retinal degeneration (HP:0001146) | 1.85628766 |
| 105 | Tetraparesis (HP:0002273) | 1.85134616 |
| 106 | T lymphocytopenia (HP:0005403) | 1.85014323 |
| 107 | Gastrointestinal inflammation (HP:0004386) | 1.84962024 |
| 108 | Gangrene (HP:0100758) | 1.84490054 |
| 109 | Premature loss of primary teeth (HP:0006323) | 1.83725893 |
| 110 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83466201 |
| 111 | Mucopolysacchariduria (HP:0008155) | 1.83466201 |
| 112 | Progressive neurologic deterioration (HP:0002344) | 1.82849264 |
| 113 | Patchy hypopigmentation of hair (HP:0011365) | 1.82477720 |
| 114 | Purpura (HP:0000979) | 1.82314159 |
| 115 | Acne (HP:0001061) | 1.81961963 |
| 116 | Joint swelling (HP:0001386) | 1.81798408 |
| 117 | Agnosia (HP:0010524) | 1.81709784 |
| 118 | Glomerulonephritis (HP:0000099) | 1.81689302 |
| 119 | IgM deficiency (HP:0002850) | 1.81434529 |
| 120 | Chronic sinusitis (HP:0011109) | 1.81030987 |
| 121 | Restrictive lung disease (HP:0002091) | 1.80318859 |
| 122 | Difficulty running (HP:0009046) | 1.79668085 |
| 123 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78345367 |
| 124 | Abnormality of the periventricular white matter (HP:0002518) | 1.77519981 |
| 125 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.77315818 |
| 126 | White forelock (HP:0002211) | 1.76640958 |
| 127 | Disinhibition (HP:0000734) | 1.76276659 |
| 128 | Bone pain (HP:0002653) | 1.76156227 |
| 129 | J-shaped sella turcica (HP:0002680) | 1.75971408 |
| 130 | Episodic fever (HP:0001954) | 1.74506624 |
| 131 | Amyloidosis (HP:0011034) | 1.72309368 |
| 132 | Vertigo (HP:0002321) | 1.71786093 |
| 133 | Abnormality of the endocardium (HP:0004306) | 1.71766253 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 1.68213674 |
| 135 | Increased serum ferritin (HP:0003281) | 1.66581158 |
| 136 | Polyneuropathy (HP:0001271) | 1.63360311 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.62679299 |
| 138 | Thin bony cortex (HP:0002753) | 1.61852345 |
| 139 | Hyperkalemia (HP:0002153) | 1.61238833 |
| 140 | Peripheral demyelination (HP:0011096) | 1.60638206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.30571136 |
| 2 | IRAK4 | 3.43570274 |
| 3 | TYK2 | 3.04393355 |
| 4 | BMPR2 | 2.91246349 |
| 5 | IKBKE | 2.64206090 |
| 6 | TBK1 | 2.49577102 |
| 7 | PRPF4B | 2.48467406 |
| 8 | IKBKB | 2.48114361 |
| 9 | TXK | 2.46417785 |
| 10 | RIPK4 | 2.43258449 |
| 11 | MAP4K1 | 2.40130640 |
| 12 | ERN1 | 2.39234672 |
| 13 | BLK | 2.30071164 |
| 14 | TRIB3 | 2.27989007 |
| 15 | PIM2 | 2.07114666 |
| 16 | SIK3 | 2.01052543 |
| 17 | MST4 | 1.92889610 |
| 18 | JAK3 | 1.92397353 |
| 19 | SIK1 | 1.92050717 |
| 20 | JAK1 | 1.86097481 |
| 21 | CASK | 1.83698006 |
| 22 | CHUK | 1.77433609 |
| 23 | KIT | 1.73215761 |
| 24 | ADRBK2 | 1.65690977 |
| 25 | GRK6 | 1.59516928 |
| 26 | EPHB1 | 1.58418561 |
| 27 | MAP3K12 | 1.55428632 |
| 28 | TEC | 1.54968533 |
| 29 | MAP3K11 | 1.53169803 |
| 30 | NEK9 | 1.51186445 |
| 31 | PBK | 1.50232481 |
| 32 | RIPK1 | 1.48075208 |
| 33 | SYK | 1.45160171 |
| 34 | GRK7 | 1.42768482 |
| 35 | MAP3K13 | 1.42614285 |
| 36 | ERBB3 | 1.42595967 |
| 37 | CLK1 | 1.40623503 |
| 38 | IRAK3 | 1.39047063 |
| 39 | CDC42BPA | 1.35886660 |
| 40 | MAP2K3 | 1.35573646 |
| 41 | YES1 | 1.27548984 |
| 42 | MARK2 | 1.23484261 |
| 43 | BCR | 1.23032801 |
| 44 | BTK | 1.22934862 |
| 45 | MAP2K6 | 1.20641054 |
| 46 | MAP3K3 | 1.19380366 |
| 47 | TAOK1 | 1.18562829 |
| 48 | MAP3K1 | 1.17547397 |
| 49 | FGFR3 | 1.13338013 |
| 50 | ZAP70 | 1.13202778 |
| 51 | DAPK2 | 1.13015977 |
| 52 | MAP2K2 | 1.12135522 |
| 53 | PIM1 | 1.10325924 |
| 54 | ARAF | 1.09971535 |
| 55 | SGK2 | 1.05530415 |
| 56 | TRPM7 | 1.03917517 |
| 57 | IRAK1 | 1.02825436 |
| 58 | MAPK12 | 1.02598535 |
| 59 | TGFBR2 | 1.01875354 |
| 60 | NEK6 | 1.00942173 |
| 61 | MAP3K7 | 1.00592826 |
| 62 | ZAK | 0.99339140 |
| 63 | HCK | 0.98802468 |
| 64 | FER | 0.98656613 |
| 65 | BMPR1B | 0.98445952 |
| 66 | EPHA3 | 0.98065114 |
| 67 | PDPK1 | 0.96955571 |
| 68 | PDK1 | 0.96646697 |
| 69 | PRKD2 | 0.94865666 |
| 70 | TESK2 | 0.91436657 |
| 71 | CAMKK1 | 0.91094830 |
| 72 | INSRR | 0.90479884 |
| 73 | MATK | 0.86933890 |
| 74 | LYN | 0.83367558 |
| 75 | OBSCN | 0.82200237 |
| 76 | EIF2AK2 | 0.79625146 |
| 77 | LCK | 0.79558354 |
| 78 | CSK | 0.79352665 |
| 79 | ACVR1B | 0.78393316 |
| 80 | FGR | 0.78268166 |
| 81 | STK24 | 0.78245579 |
| 82 | NLK | 0.77932911 |
| 83 | CAMKK2 | 0.76489205 |
| 84 | MAP3K2 | 0.76427002 |
| 85 | PKN2 | 0.75428031 |
| 86 | SGK223 | 0.75256649 |
| 87 | SGK494 | 0.75256649 |
| 88 | PRKCD | 0.73213987 |
| 89 | ITK | 0.72826262 |
| 90 | SGK3 | 0.70398893 |
| 91 | PTK6 | 0.69937053 |
| 92 | MAP2K7 | 0.69712826 |
| 93 | FES | 0.69676715 |
| 94 | JAK2 | 0.69648507 |
| 95 | MAP2K4 | 0.67337857 |
| 96 | IRAK2 | 0.66252701 |
| 97 | PRKAA2 | 0.65806157 |
| 98 | CSF1R | 0.65009584 |
| 99 | MAPKAPK2 | 0.64123524 |
| 100 | PRKCQ | 0.64093166 |
| 101 | PRKCE | 0.61989875 |
| 102 | RET | 0.61368807 |
| 103 | RPS6KA6 | 0.61089154 |
| 104 | HIPK2 | 0.60765034 |
| 105 | CAMK1D | 0.60332008 |
| 106 | STK4 | 0.59204117 |
| 107 | DYRK1B | 0.58405460 |
| 108 | MAPK15 | 0.56536476 |
| 109 | TAOK3 | 0.55915515 |
| 110 | PKN1 | 0.54117291 |
| 111 | TNIK | 0.53815447 |
| 112 | MAP3K6 | 0.52854064 |
| 113 | FRK | 0.51751439 |
| 114 | FGFR4 | 0.51583953 |
| 115 | ABL2 | 0.50193358 |
| 116 | PRKD1 | 0.49182914 |
| 117 | RPS6KC1 | 0.48143705 |
| 118 | RPS6KL1 | 0.48143705 |
| 119 | SIK2 | 0.48015230 |
| 120 | PHKG2 | 0.46172102 |
| 121 | PHKG1 | 0.46172102 |
| 122 | GRK1 | 0.44898651 |
| 123 | STK11 | 0.43734295 |
| 124 | MARK3 | 0.43652543 |
| 125 | MAP2K1 | 0.42507994 |
| 126 | AKT3 | 0.40132392 |
| 127 | MAPKAPK5 | 0.38280137 |
| 128 | ABL1 | 0.37122843 |
| 129 | TNK2 | 0.32888043 |
| 130 | PRKCH | 0.32552490 |
| 131 | RPS6KB1 | 0.31272204 |
| 132 | RPS6KA5 | 0.31166188 |
| 133 | MOS | 0.30419044 |
| 134 | NUAK1 | 0.29619967 |
| 135 | RPS6KA2 | 0.28738926 |
| 136 | BMX | 0.26501020 |
| 137 | MAPK7 | 0.26385651 |
| 138 | PLK2 | 0.25352277 |
| 139 | PIK3CG | 0.23517837 |
| 140 | MAPK3 | 0.23239676 |
| 141 | TIE1 | 0.23193265 |
| 142 | GRK5 | 0.22846162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.23200046 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.09691822 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66479058 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57422448 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.50701151 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.47338125 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47325387 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38894374 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.21621091 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17765653 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01905566 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00971518 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92113890 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91876160 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91503142 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.87382663 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80194646 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.79358886 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.76727312 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.73986911 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71626583 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.66063309 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.65351496 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.63049348 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.59960945 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.57030909 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53094908 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50673185 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48374035 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45837657 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45307791 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43239551 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40138371 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38153282 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.36870146 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36305776 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35579105 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.35372327 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34049960 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31158103 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27004144 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.21061220 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19944119 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.19137430 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13552916 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.10742746 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10053818 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08662605 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07117933 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99459730 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 0.99275814 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.99080604 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94676487 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91681828 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88019956 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.87223889 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.83746231 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83103328 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83034873 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81834178 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78869772 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77149205 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76594334 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.75170662 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73953693 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73823106 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73482706 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71528293 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.71250962 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70641310 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70610000 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69681638 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68240487 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68174797 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67897791 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67582733 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65840736 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65519677 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64510123 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63193447 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61919045 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61765160 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59522175 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59439915 |
| 85 | * ABC transporters_Homo sapiens_hsa02010 | 0.57347959 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56341299 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56246626 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.55369337 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55305089 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54880788 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54647253 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54259907 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.53302371 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53143886 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.49825444 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49142444 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48850875 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48821112 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.48450377 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47649812 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47444437 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46966338 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45835155 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45610149 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45217691 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44506626 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43895943 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42992399 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42920121 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40161620 |
| 111 | Morphine addiction_Homo sapiens_hsa05032 | 0.38362373 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37993954 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37373018 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36852785 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34866964 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34856645 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34351720 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32906753 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31778559 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30969952 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.30551535 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28723778 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27330486 |
| 124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26341208 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26186806 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25208081 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.25113744 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24882015 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24808256 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.23875976 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22369041 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22032602 |
| 133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21091948 |
| 134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20950090 |

